TRIM33 and dermatomyositis: Since the earliest reports dating back to 1916 (25), several studies have confirmed a strong link between cancer and IIM, particularly with DM and in the presence of autoantibodies targeting transcription intermediary factor 1γ (TIF1-γ) and the nuclear matrix protein 2 (NXP2) (26, 27).